JusticeItaly Official institution
Italy changes marketing permission for blood-thinner Apixaban Sun
Italy's medicines agency AIFA has published an official notice changing the marketing permission for Apixaban Sun, a human medicine containing apixaban. The notice is filed under reference 26A05647. The short excerpt does not say what the change is, so the details must be checked in the official source.
This summary was generated by AI; the official source prevails.
What does it mean?
Apixaban Sun is a medicine that can be sold in Italy only under an official permission, and that permission has been changed. The notice does not say what the change is, so it is not clear from this text whether patients or pharmacies will notice anything.
Who is affected?
Patients who take Apixaban Sun and the companies and pharmacies that handle it in Italy.